Surprisingly, a recent study suggests that EDAR is robustly expressed in human breast cancers and its elevation induces the expression of multiple genes in the WNT pathway, which is highly correlated with breast cancer [38]. The gene discussed is EDAR; the disease is breast carcinoma.